XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
KUAISHOU-W
01024
BIDU-SW
09888
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 109.27%5.97M | ---- | 27.10%-64.39M | ---- | -14.34%-88.34M | ---- | -258.03%-77.26M | ---- | -2.49%48.89M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -117.57%-104.74M | ---- | -172.05%-48.14M | ---- | 46.87%-17.7M | ---- | 21.57%-33.3M | ---- | 15.63%-42.46M |
Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 44.27%-5.55M |
Impairment and provisions: | ---- | 144.41%27.77M | ---- | -15.46%11.36M | ---- | -69.24%13.44M | ---- | 1,144.22%43.7M | ---- | 85.92%3.51M |
-Impairment of property, plant and equipment (reversal) | ---- | 154.57%22.92M | ---- | 29.47%9M | ---- | -83.37%6.95M | ---- | --41.82M | ---- | ---- |
-Impairmen of inventory (reversal) | ---- | ---- | ---- | -79.07%36K | ---- | -40.48%172K | ---- | -38.77%289K | ---- | --472K |
-Other impairments and provisions | ---- | 108.86%4.86M | ---- | -63.19%2.33M | ---- | 297.48%6.32M | ---- | -47.73%1.59M | ---- | 60.93%3.04M |
Revaluation surplus: | ---- | -167.32%-20.69M | ---- | 54.13%30.73M | ---- | 571.01%19.94M | ---- | 93.30%-4.23M | ---- | -78.56%-63.17M |
-Fair value of investment properties (increase) | ---- | -167.32%-20.69M | ---- | 54.13%30.73M | ---- | 571.01%19.94M | ---- | 93.30%-4.23M | ---- | -78.56%-63.17M |
Asset sale loss (gain): | ---- | 103.04%368K | ---- | -290.00%-12.1M | ---- | 2,287.97%6.37M | ---- | -127.53%-291K | ---- | 452.33%1.06M |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | 98.64%-32K | ---- | ---2.36M | ---- | ---- | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | 103.06%373K | ---- | -16,358.67%-12.19M | ---- | 141.94%75K | ---- | -96.84%31K | ---- | -6.48%981K |
-Loss (gain) from selling other assets | ---- | -103.88%-5K | ---- | -98.51%129K | ---- | 2,785.71%8.65M | ---- | -523.68%-322K | ---- | 65.22%76K |
Depreciation and amortization: | ---- | -6.08%41.96M | ---- | -58.00%44.68M | ---- | 10.57%106.37M | ---- | 7.93%96.2M | ---- | 191.47%89.13M |
-Depreciation | ---- | -6.16%40.43M | ---- | -58.86%43.09M | ---- | 10.64%104.72M | ---- | 8.09%94.65M | ---- | 202.41%87.57M |
-Other depreciation and amortization | ---- | -4.01%1.53M | ---- | -3.33%1.6M | ---- | 6.38%1.65M | ---- | -0.83%1.55M | ---- | -3.57%1.57M |
Financial expense | ---- | 138.55%36.47M | ---- | -49.34%15.29M | ---- | -11.87%30.18M | ---- | 8.32%34.24M | ---- | 44.22%31.61M |
Special items | ---- | ---- | ---- | ---- | ---- | -965.85%-32.24M | ---- | ---3.03M | ---- | ---- |
Operating profit before the change of operating capital | ---- | 42.92%-12.88M | ---- | -159.36%-22.57M | ---- | -32.14%38.02M | ---- | -11.09%56.03M | ---- | 636.60%63.02M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 41.74%-25.38M | ---- | -51.82%-43.57M | ---- | -214.16%-28.7M | ---- | -14.20%25.14M | ---- | 169.11%29.3M |
Accounts receivable (increase)decrease | ---- | -175.13%-107.15M | ---- | 26.21%142.63M | ---- | 161.56%113.01M | ---- | -548.14%-183.59M | ---- | 3.12%40.97M |
Accounts payable increase (decrease) | ---- | 124.52%32.58M | ---- | -1,426.76%-132.84M | ---- | 46.88%-8.7M | ---- | -119.68%-16.38M | ---- | 133.05%83.26M |
Financial assets at fair value (increase)decrease | ---- | -756.52%-151K | ---- | 428.57%23K | ---- | 0.00%-7K | ---- | -240.00%-7K | ---- | -99.98%5K |
Special items for working capital changes | ---- | 5,547.36%129.61M | ---- | 102.56%2.3M | ---- | -151.78%-89.74M | ---- | 141.29%173.31M | ---- | -153.56%-419.76M |
Cash from business operations | -1,602.05%-140.89M | 130.75%16.61M | -64.95%9.38M | -326.14%-54.03M | 100.94%26.76M | -56.16%23.89M | -1,549.83%-2.86B | 126.82%54.5M | 274.60%197.35M | -132.93%-203.22M |
Hong Kong profits tax paid | 31.49%-966K | 62.64%-2.53M | ---1.41M | -180.07%-6.76M | ---- | 81.61%-2.41M | ---- | ---13.12M | ---- | ---- |
Other taxs | 21.46%-1.9M | -41.16%-8.08M | 4.05%-2.42M | 67.88%-5.72M | 67.10%-2.52M | -39.65%-17.82M | 32.49%-7.66M | -119.40%-12.76M | -223.65%-11.35M | -146.50%-5.82M |
Net cash from operations | -2,689.28%-143.76M | 109.04%6.01M | -77.10%5.55M | -1,916.22%-66.51M | 100.84%24.24M | -87.21%3.66M | -1,642.40%-2.87B | 113.69%28.62M | 259.61%186.01M | -134.77%-209.04M |
Cash flow from investment activities | ||||||||||
Interest received - investment | -3.27%49.66M | 187.17%106.35M | 458.35%51.34M | 106.85%37.03M | 34.69%9.2M | -49.00%17.9M | -66.27%6.83M | -21.47%35.1M | -15.43%20.24M | -3.26%44.7M |
Dividend received - investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -4.84%6.58M |
Decrease in deposits (increase) | -436.23%-4.63M | -24.61%4.38M | -111.96%-864K | -52.65%5.81M | 130.28%7.22M | 216.40%12.27M | -8.21%-23.86M | -122.26%-10.54M | -157.98%-22.05M | 226.69%47.35M |
Sale of fixed assets | -70.99%85K | -99.61%150K | -99.24%293K | 4,325.34%38.59M | 4,968.20%38.57M | 868.89%872K | 1,127.42%761K | 650.00%90K | --62K | -98.34%12K |
Purchase of fixed assets | 10.06%-3.12M | 69.75%-2.83M | -57.04%-3.47M | -27.64%-9.37M | 56.82%-2.21M | 62.20%-7.34M | -57.90%-5.12M | 58.17%-19.42M | 85.33%-3.24M | 69.64%-46.42M |
Sale of subsidiaries | --49.95M | ---- | ---- | ---- | ---- | -100.00%8K | -100.00%8K | --204.19M | --204.19M | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 35.57%-1.91M |
Recovery of cash from investments | -86.96%1.18M | 18.42%22.39M | -6.07%9.02M | -26.03%18.91M | 539.44%9.6M | 74.71%25.56M | -58.76%1.5M | 421.01%14.63M | 86.28%3.64M | -73.79%2.81M |
Cash on investment | ---- | -265.23%-15.54M | ---15.43M | ---4.25M | ---- | ---- | ---- | ---- | ---- | ---- |
Net cash from investment operations | 127.77%93.12M | 32.50%114.89M | -34.46%40.88M | 76.00%86.71M | 413.80%62.38M | -78.01%49.27M | -109.80%-19.88M | 321.84%224.06M | 319.01%202.85M | 146.99%53.12M |
Net cash before financing | -209.04%-50.64M | 498.45%120.91M | -46.39%46.44M | -61.83%20.2M | 103.00%86.62M | -79.05%52.93M | -842.91%-2.89B | 262.05%252.68M | 670.78%388.85M | -131.94%-155.92M |
Cash flow from financing activities | ||||||||||
New borrowing | 0.00%118M | 0.00%118M | --118M | -96.13%118M | ---- | 2,002.58%3.05B | 2,021.94%2.97B | -46.04%145M | -5.41%140M | 279.26%268.72M |
Refund | -8.12%-142.24M | 9.98%-164.55M | -110.10%-131.56M | 94.01%-182.79M | 62.15%-62.62M | -1,319.31%-3.05B | 22.04%-165.43M | -36.56%-215M | -90.59%-212.19M | 64.66%-157.44M |
Issuing shares | ---- | 3,455.88%66.25M | ---- | -94.61%1.86M | --1.86M | --34.54M | ---- | ---- | ---- | ---- |
Interest paid - financing | 22.64%-10.92M | -98.15%-30.28M | -131.54%-14.12M | 49.02%-15.28M | 56.96%-6.1M | 11.95%-29.98M | -51.35%-14.17M | -7.71%-34.05M | 4.29%-9.36M | -37.06%-31.61M |
Dividends paid - financing | ---450K | 86.42%-146K | ---- | -1.42%-1.08M | ---- | ---1.06M | ---- | ---- | ---- | ---- |
Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --400K | ---- | ---- |
Net cash from financing operations | -22.50%-42.55M | 72.99%-24.94M | 52.74%-34.73M | -105.65%-92.35M | -102.66%-73.49M | 70.39%-44.91M | 2,573.31%2.76B | -542.82%-151.68M | -22,410.18%-111.77M | 108.61%34.25M |
Effect of rate | 61.71%-790K | 88.18%-1.07M | 59.61%-2.06M | -389.97%-9.08M | -502.20%-5.11M | -61.94%3.13M | 162.50%1.27M | 412.42%8.22M | -149.33%-2.03M | 44.34%-2.63M |
Net Cash | -896.31%-93.18M | 233.00%95.96M | -10.84%11.7M | -999.29%-72.15M | 110.56%13.13M | -92.06%8.02M | -144.86%-124.29M | 183.01%101M | 509.72%277.08M | -234.43%-121.67M |
Begining period cash | 37.91%340.62M | -24.75%247M | -24.75%247M | 3.52%328.22M | 3.52%328.22M | 52.55%317.07M | 52.55%317.07M | -37.42%207.85M | -37.42%207.85M | 34.82%332.15M |
Items Period | ---- | ---1.27M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash at the end | -3.89%246.65M | 37.91%340.62M | -23.67%256.64M | -24.75%247M | 73.28%336.24M | 3.52%328.22M | -59.82%194.05M | 52.55%317.07M | 83.11%482.89M | -37.42%207.85M |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.